Pluri Receives First-Ever Patent for 3D Bioreactor Technology in Plant Cell Cultivation
Pluri (Nasdaq:PLUR) (TASE:PLUR), parent company of the recently launched cell-based coffee biotech PluriAgtech, announces that it has secured a patent from the Israel Patent Office for its “System for 3D Cultivation of Plant Cells and Methods of Use.” Pluri claims this is the first-ever patent approval for 3D bioreactor technology in plant cell cultivation. Pluri’s 3D technology enables the cultivation of plant cells in bioreactors to develop sustainable and disease-free plant …
PluriAgtech Introduces Cell-Based Coffee to Provide an Alternative to Traditional Production
Israeli biotechnology firm Pluri, formerly Pluristem, (Nasdaq, TASE: PLUR) has launched PluriAgtech, a subsidiary leveraging plant cell culture to grow sustainable coffee and break away from traditional farming methods. As global warming continues to impact the coffee industry, shrinking viable land for cultivation and increasing demand leads to higher prices and less production. According to the company, by 2050, land for coffee production will be reduced by half, and 30% …